What is HC Wainwright’s Forecast for Transcat Q1 Earnings?

Transcat, Inc. (NASDAQ:TRNSFree Report) – Equities researchers at HC Wainwright issued their Q1 2026 earnings per share estimates for Transcat in a research report issued to clients and investors on Wednesday, May 21st. HC Wainwright analyst S. Buck forecasts that the scientific and technical instruments company will earn $0.41 per share for the quarter. HC Wainwright has a “Buy” rating and a $116.00 price target on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share. HC Wainwright also issued estimates for Transcat’s Q2 2026 earnings at $0.26 EPS, Q3 2026 earnings at $0.10 EPS and FY2026 earnings at $1.48 EPS.

Transcat (NASDAQ:TRNSGet Free Report) last issued its quarterly earnings data on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.66 by ($0.02). Transcat had a net margin of 6.22% and a return on equity of 7.23%. The company had revenue of $77.13 million for the quarter, compared to analysts’ expectations of $76.40 million. The business’s revenue was up 8.8% compared to the same quarter last year.

Other equities research analysts also recently issued reports about the company. Oppenheimer downgraded Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Northland Securities reiterated a “market perform” rating and issued a $85.00 price target (down from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Finally, Wall Street Zen upgraded Transcat from a “sell” rating to a “hold” rating in a report on Tuesday. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Transcat currently has an average rating of “Hold” and a consensus price target of $114.00.

Check Out Our Latest Report on TRNS

Transcat Trading Down 0.3%

Shares of TRNS stock opened at $91.32 on Friday. Transcat has a 1 year low of $67.56 and a 1 year high of $147.12. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The stock’s 50 day simple moving average is $79.46 and its two-hundred day simple moving average is $89.73. The company has a market cap of $850.10 million, a PE ratio of 49.36 and a beta of 0.69.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Conestoga Capital Advisors LLC increased its position in shares of Transcat by 5.8% during the first quarter. Conestoga Capital Advisors LLC now owns 957,254 shares of the scientific and technical instruments company’s stock worth $71,268,000 after acquiring an additional 52,328 shares during the period. Neuberger Berman Group LLC boosted its stake in Transcat by 5.5% in the first quarter. Neuberger Berman Group LLC now owns 921,898 shares of the scientific and technical instruments company’s stock valued at $68,635,000 after acquiring an additional 47,913 shares in the last quarter. T. Rowe Price Investment Management Inc. boosted its stake in Transcat by 17.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 607,360 shares of the scientific and technical instruments company’s stock valued at $45,218,000 after acquiring an additional 88,763 shares in the last quarter. Champlain Investment Partners LLC boosted its stake in shares of Transcat by 7.6% during the first quarter. Champlain Investment Partners LLC now owns 598,026 shares of the scientific and technical instruments company’s stock worth $44,523,000 after buying an additional 42,376 shares during the period. Finally, Royce & Associates LP boosted its stake in shares of Transcat by 1.1% during the first quarter. Royce & Associates LP now owns 478,581 shares of the scientific and technical instruments company’s stock worth $35,630,000 after buying an additional 5,327 shares during the period. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Company Profile

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More

Earnings History and Estimates for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.